GENERATION OF AN INDUCIBLE SYSTEM IN THE UTERINE STROMA FOR IMPLANTATION STUDIES

用于植入研究的子宫间质中诱导系统的生成

基本信息

  • 批准号:
    8522211
  • 负责人:
  • 金额:
    $ 18.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-03 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human infertility is a global problem and failure of embryo implantation accounts for a significant percentage of pregnancy failure during both natural pregnancy and in vitro fertilization procedures. Implantation is an extremely complicated process requiring precisely controlled hormonal, growth factor signaling and cell-cell contacts which coordinate interactions between the competent blastocysts and the receptive uterus. In the past two decades we have greatly improved our knowledge on this subject by using sophisticated mouse genetics. However, our understanding of implantation is still rudimentary. Implantation research including the study of uterine receptivity and decidualization has benefited greatly from the Cre/LoxP technology which allows functional study of many genes in a tissue specific manner. Although inducible Cre/LoxP systems have been widely used in other fields of studies, their use in implantation studies has been limited by the steroidal nature of most of the inducers which interferes with the implantation process. The currently used Pgr-Cre and Amhr2-Cre lines are not inducible and each has their own limitations for implantation studies. Thus there is urgent need to develop an inducible tissue-specific Cre system for conditional deletion of genes in the uterus during implantation. In this proposal, we propose to knock rtTA into the endogenous Gli2 locus to generate a tetracycline-inducible line which in corporation with tetO-Cre can drive inducible Cre expression in the uterine stroma during implantation. In Aim I we will use BAC recombineering to generate a knock-in construct which will be used for gene targeting in ES cells and eventually germline chimera production. In Aim II, we will assess the usefulness of this knock-in allele in implantation studies. This mouse strain should be a valuable tool for researchers studying implantation as well as embryonic or postnatal organogenesis and carcinogenesis.
描述(申请人提供):人类不孕不育是一个全球性的问题,胚胎植入失败是自然妊娠和体外受精过程中妊娠失败的重要原因。着床是一个极其复杂的过程,需要精确控制激素、生长因子信号和细胞-细胞接触,以协调合格胚泡和接受子宫之间的相互作用。在过去的二十年里,我们通过使用复杂的小鼠遗传学极大地提高了我们对这一主题的了解。然而,我们对植入的理解仍然是初级的。着床研究,包括子宫容受性和蜕膜化的研究,极大地得益于CRE/loxP技术,它允许以组织特异性的方式研究许多基因的功能。尽管可诱导的Cre/loxP系统在其他领域的研究中得到了广泛的应用,但它们在植入研究中的应用受到了大多数干扰植入过程的诱导剂的类固醇性质的限制。目前使用的PGR-Cre和Amhr2-Cre系是不可诱导的,它们在植入研究中都有自己的局限性。因此,迫切需要开发一种可诱导的组织特异性Cre系统,用于在植入过程中有条件地删除子宫中的基因。在这个方案中,我们建议将RTTA敲击到内源Gli2基因座上,以产生一个四环素诱导的株系,与Teto-Cre一起,可以在着床过程中驱动子宫间质中可诱导的Cre表达。在目标I中,我们将使用BAC重组工程来产生敲入结构,该结构将用于在ES细胞中进行基因靶向,并最终产生生殖系嵌合体。在AIM II中,我们将评估这种敲入等位基因在植入研究中的有效性。这种小鼠品系应该是研究植入以及胚胎或出生后器官发生和癌症的研究人员的有价值的工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Liang Ma其他文献

Liang Ma的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Liang Ma', 18)}}的其他基金

Androgen and Wnt signaling in bladder cancer
膀胱癌中的雄激素和 Wnt 信号传导
  • 批准号:
    10727745
  • 财政年份:
    2023
  • 资助金额:
    $ 18.87万
  • 项目类别:
Retinoic acid signaling in decidualization
蜕膜化中的视黄酸信号传导
  • 批准号:
    10280145
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
Retinoic acid signaling in decidualization
蜕膜化中的视黄酸信号传导
  • 批准号:
    10619637
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
GENITALIA OUTGROWTH AND HYPOSPADIAS
生殖器生长和尿道下裂
  • 批准号:
    9317645
  • 财政年份:
    2017
  • 资助金额:
    $ 18.87万
  • 项目类别:
GENOME-WIDE IDENTIFICATION OF GENES REQUIRED FOR DECIDUALIZATION
蜕化所需基因的全基因组鉴定
  • 批准号:
    9258455
  • 财政年份:
    2016
  • 资助金额:
    $ 18.87万
  • 项目类别:
AN IN VITRO SCREENING TOOL FOR DECIDUALIZATION
一种用于分化的体外筛选工具
  • 批准号:
    8969886
  • 财政年份:
    2015
  • 资助金额:
    $ 18.87万
  • 项目类别:
GENERATION OF AN INDUCIBLE SYSTEM IN THE UTERINE STROMA FOR IMPLANTATION STUDIES
用于植入研究的子宫间质中诱导系统的生成
  • 批准号:
    8358586
  • 财政年份:
    2012
  • 资助金额:
    $ 18.87万
  • 项目类别:
EXTERNAL GENITALIA DEVELOPMENT AND HYPOSPADIAS
外生殖器发育和尿道下裂
  • 批准号:
    7656161
  • 财政年份:
    2009
  • 资助金额:
    $ 18.87万
  • 项目类别:
EXTERNAL GENITALIA DEVELOPMENT AND HYPOSPADIAS
外生殖器发育和尿道下裂
  • 批准号:
    8265869
  • 财政年份:
    2009
  • 资助金额:
    $ 18.87万
  • 项目类别:
Novel effectors of ERK signaling and their potential roles in the treatment of en
ERK 信号传导的新型效应物及其在治疗 en 中的潜在作用
  • 批准号:
    7727351
  • 财政年份:
    2009
  • 资助金额:
    $ 18.87万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 18.87万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 18.87万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 18.87万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 18.87万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 18.87万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 18.87万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 18.87万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 18.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了